Verve Therapeutics, Inc. (VERV) Analyst Forecast

$6.41

north_east
$0.17 (2.72%)
Day's range
$6.21
Day's range
$6.87

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/06/2024 H.C. Wainwright Mitchell Kapoor $14.00 $6.32   121.69%
04/03/2024 BMO Capital Kostas Biliouris $30.00 $8.57   250.06%

Verve Therapeutics, Inc. FAQ's

Verve Therapeutics, Inc. has been rated by research analysts at RBC Capital, H.C. Wainwright, BMO Capital, Goldman Sachs in the past 90 days.